MADDON PAUL J 4
4 · PROGENICS PHARMACEUTICALS INC · Filed Sep 2, 2010
Insider Transaction Report
Form 4
MADDON PAUL J
Chief Executive Officer/CSO10% Owner
Transactions
- Purchase
Common Stock
2010-09-01$4.10/sh+5,000$20,500→ 839,057 total
Footnotes (2)
- [F1]Open market purchase pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- [F2]This transaction was executed in multiple trades at prices ranging from $4.09 to $4.12. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.